Celltrion Launches US Media Advertising for Zimpentra

Celltrion has launched a media advertising campaign in the US for Zimpentra, a subcutaneous injection (SC) form of infliximab. The goal of the campaign is to increase awareness of Zimpentra and lead to accelerated prescriptions.

The advertising campaign will include YouTube advertisements across the US and TV advertisements through several TV channels and OTT platforms starting next month. The advertisements will highlight the benefits of Zimpentra, including its ease of administration and ability to improve patients’ quality of life.

The advertisements will depict patients who have difficulty leading a daily life due to regular in-hospital treatment for autoimmune diseases. After consulting with a doctor, the patients select Zimpentra, which can be self-administered, and are able to enjoy a more free and active life.

Zimpentra is a product that improves the dosing convenience of infliximab, which has proven therapeutic efficacy and safety in medical settings for over 20 years. It has already recorded growth based on high patient satisfaction in Europe and other parts of the world.

Celltrion plans to expand the scope of its media advertising campaign to include social media platforms such as Instagram and LinkedIn. The company will also review point-of-care (POC) advertisements that can be easily accessed by patients at the prescription site, such as on hospital attachments, printed materials, and outdoor media.

Thomas Nuswickel, Chief Commercial Officer (CCO) of Celltrion’s US subsidiary, said, “With this Zimpentra media advertisement, American autoimmune disease patients will learn about new treatment options. More patients will be able to enjoy the benefits of Celltrion treatments. We will strengthen our sales capabilities to enable this.”

Key Benefits of Zimpentra

• Improves dosing convenience of infliximab
• Proven therapeutic efficacy and safety in medical settings for over 20 years
• Self-administered, reducing the need for regular in-hospital treatment
• Improves patients’ quality of life

About Celltrion

Celltrion is a biopharmaceutical company that develops and manufactures innovative treatments for autoimmune diseases. The company’s mission is to improve patients’ lives by providing safe and effective treatments.